Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Comera Life Sciences Holdings, Inc. (CMRA) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Comera Life Sciences Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1907685.
Total stock buying since 2022: $2,344,073.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 3,557,883 | $1,961,697 | 0 | $0 | 0 | $0 |
| 2022 | 200,507 | $382,376 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-11 | 10,000 | $709 | 0 | $0 | 0 | $0 |
| 2023-09 | 2,171,149 | $1,109,456 | 0 | $0 | 0 | $0 |
| 2023-08 | 20,000 | $12,500 | 0 | $0 | 0 | $0 |
| 2023-07 | 1,154,033 | $589,710 | 0 | $0 | 0 | $0 |
| 2023-01 | 202,701 | $249,322 | 0 | $0 | 0 | $0 |
| 2022-11 | 3,000 | $4,149 | 0 | $0 | 0 | $0 |
| 2022-10 | 45,007 | $73,230 | 0 | $0 | 0 | $0 |
| 2022-09 | 152,500 | $304,997 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-27 | Campbell Michael Gerard (EVP & CFO) | Buy | 10,000 | .07 | 709 |
| 2023-09-11 | Soane Family Trust (10% Owner) | Buy | 117,360 | .51 | 59,970 |
| 2023-09-11 | Cherington Charles | Buy | 2,053,789 | .51 | 1,049,486 |
| 2023-08-14 | Mahoney Robert Patrick (Chief Scientific Officer) | Buy | 20,000 | .62 | 12,500 |
| 2023-07-31 | Soane Family Trust (10% Owner) | Buy | 273,838 | .51 | 139,931 |
| 2023-07-31 | Cherington Charles | Buy | 880,195 | .51 | 449,779 |
| 2023-01-04 | Soane David (10% Owner) | Buy | 202,701 | 1.23 | 249,322 |
| 2022-11-08 | Soane Family Trust (10% Owner) | Buy | 3,000 | 1.38 | 4,149 |
| 2022-10-21 | Cherington Charles (10% Owner) | Buy | 11,691 | 1.59 | 18,635 |
| 2022-10-20 | Cherington Charles (10% Owner) | Buy | 3,316 | 1.52 | 5,046 |
| 2022-10-17 | Cherington Charles (10% Owner) | Buy | 15,266 | 1.66 | 25,341 |
| 2022-10-14 | Cherington Charles (10% Owner) | Buy | 4,253 | 1.60 | 6,821 |
| 2022-10-13 | Cherington Charles (10% Owner) | Buy | 10,481 | 1.66 | 17,387 |
| 2022-09-29 | Cherington Charles (10% Owner) | Buy | 17,900 | 1.87 | 33,473 |
| 2022-09-27 | Cherington Charles (10% Owner) | Buy | 12,000 | 1.69 | 20,220 |
| 2022-09-12 | Sherblom James (Director) | Buy | 50,000 | 2.03 | 101,499 |
| 2022-09-09 | Hackman Jeffrey S. (See Remarks) | Buy | 47,600 | 2.06 | 98,056 |
| 2022-09-08 | Campbell Michael Gerard (EVP & CFO) | Buy | 25,000 | 2.07 | 51,749 |
Insider trading activities including stock purchases, stock sales, and option exercises of CMRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Comera Life Sciences Holdings, Inc. (symbol CMRA, CIK number 1907685) see the Securities and Exchange Commission (SEC) website.